🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for PDAC - Pancreatic Ductal Adenocarcinoma

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation NCT06843551Phase 21 site📍 Miami Benjamin Spieler · Tests: Stereotactic Body Radiation Therapy, Botensilimab, Balstilimab Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009n/a1 site📍 Jinan Qilu Hospital of Shandong University · Tests: Pancreatic elastase-1 in blood serum Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy NCT04881487NA3 sites📍 Amsterdam📍 Rotterdam📍 Utrecht UMC Utrecht · Tests: Additional stereotactic body radiation therapy Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening NCT06549725NA16 sites📍 Prague📍 Brno📍 Brno Lipidica, a.s. · Tests: software Lipidica, endoscopic ultrasonography, magnetic resonance, laboratory examination, computed tomography Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC) NCT07217717Phase 319 sites📍 Cerritos📍 Duarte📍 Irvine SOFIE · Tests: [18F]FAPI-74 PET/CT A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma NCT06261359Phase 21 site📍 Beijing Qilu Pharmaceutical Co., Ltd. · Tests: CEND-1, Gemcitabine, Nab paclitaxel Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC NCT07145450Phase 1, Phase 210 sites📍 Copenhagen📍 Berlin📍 Dresden Anocca AB · Tests: ANOC-001 (TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles), ANOC-002 (TCR-T cells targeting … Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC NCT07500259n/a1 site📍 Luxembourg Luxembourg Institute of Health · Tests: Personalized Functional Profiling Pancreatic Cancer Early Detection Consortium NCT04970056n/a60 sites📍 Phoenix📍 Scottsdale📍 Burbank Arbor Research Collaborative for Health Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer NCT07408505NA1 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Nano-crystalline megestrol acetate, First-line Chemotherapy Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) NCT07262957Phase 41 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: HOP bundle TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors NCT07360314Phase 19 sites📍 New Haven📍 Huntersville📍 Galveston EMD Serono Research & Development Institute, Inc. · Tests: M7437, M7437 KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites📍 Phoenix📍 Tucson📍 Los Angeles Kura Oncology, Inc. · Tests: Darlifarnib, Cabozantinib, Adagrasib AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors NCT07094113Phase 139 sites📍 Duarte📍 Los Angeles📍 Atlanta Amgen · Tests: AMG 410, Pembrolizumab, Panitumumab Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis NCT07030283Phase 11 site📍 Aurora University of Colorado, Denver · Tests: Paclitaxel, NALIRIFOX Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer NCT06984562NA1 site📍 Philadelphia Fox Chase Cancer Center · Tests: Adaptive Radiation Therapy Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas NCT07155525NA1 site📍 Minya Minia University · Tests: Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2), Standard(duct-to-mucosa) Pancreaticojejunost… IBI343 in Combination Therapy for Advanced Malignant Solid Tumors NCT07483554Phase 21 site📍 Hangzhou Innovent Biologics (Suzhou) Co. Ltd. · Tests: IBI343,Gemcitabine, Albumin-bound Paclitaxel Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy NCT06747845Phase 22 sites📍 Boston📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: Niraparib, FOLFIRI, Ipilimumab Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer NCT04969731Phase 31 site📍 Seoul GC Cell Corporation · Tests: Immuncell-LC, Gemcitabine Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041Phase 16 sites📍 Darlinghurst📍 Randwick📍 Westmead Myeloid Therapeutics · Tests: MT-302 (A) Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma NCT07805954Phase 35 sites📍 Phoenix📍 Scottsdale📍 Jacksonville Revolution Medicines, Inc. · Tests: daraxonrasib, gemcitabine, nab-paclitaxel, zoldonrasib Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB) NCT06666803NA2 sites📍 Strasbourg📍 Strasbourg IHU Strasbourg · Tests: FNB sampling, blood sampling Advanced Therapies for Liver Metastases NCT04622423n/a1 site📍 Milan IRCCS San Raffaele Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer NCT05254171Phase 2, Phase 393 sites📍 Hot Springs📍 Fullerton📍 New Haven Panbela Therapeutics, Inc. · Tests: SBP-101, Nab-paclitaxel, Gemcitabine, Placebo Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) NCT05482893Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Denver Phanes Therapeutics · Tests: Spevatamig (PT886), Paclitaxel, Gemcitabine, Abraxane, KEYTRUDA® (pembrolizumab) Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma NCT06427239Phase 1, Phase 21 site📍 Shanghai Fudan University · Tests: HRS-4642, Adebrelimab, SHR-8068, Faminitib or bevacizumab A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites📍 Phoenix📍 Scottsdale📍 Duarte Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT06790602Phase 21 site📍 La Jolla University of California, San Diego · Tests: Cemiplimab Plus Gemcitabine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy